CYBERCLAZ INCORPORATION PTE. LTD.
UEN: 201820485D
CYBERCLAZ INCORPORATION PTE. LTD.(201820485D) is a Singapore business with registered business address at 23 NEW INDUSTRIAL ROAD, 4-8, SOLSTICE BUSINESS CENTER, Singapore 536209. They specialise in the area of DEVELOPMENT OF OTHER SOFTWARE AND PROGRAMMING ACTIVITIES N.E.C. and INFORMATION TECHNOLOGY CONSULTANCY (EXCEPT CYBERSECURITY).
| Company Name | CYBERCLAZ INCORPORATION PTE. LTD. |
| Unique Entity Number | 201820485D |
| Entity Type | Local Company |
| Entity Status | Live Company |
| Incorporate Day | 15 June 2018 |
| Address |
23 NEW INDUSTRIAL ROAD #4-8 SOLSTICE BUSINESS CENTER Singapore 536209 |
| Products / Services |
DEVELOPMENT OF OTHER SOFTWARE AND PROGRAMMING ACTIVITIES N.E.C. INFORMATION TECHNOLOGY CONSULTANCY (EXCEPT CYBERSECURITY) |
| Number of Officers | 4 |
| Paid Up Capital | SGD 100 |
Breaking! Business News
Virtusa Named a Leader in Digital Process Automation by Independent Research FirmVirtusa Named a Leader in Digital Process Automation by Independent Research Firm Globe...
Read More
Record Monthly Volume on FXCM Stock BasketsRecord Monthly Volume on FXCM Stock Baskets GlobeNewswire September 23, ...
Read More
Kargo and AMP Project Partner To Bring Optimised Mobile Creative To AMP Kargo and AMP Project Partner To Bring Optimised Mobile Creative To AMP GlobeNewswire...
Read More
ConnectWise Launches Bug Bounty Program to Help Detect Security VulnerabilitiesConnectWise Launches Bug Bounty Program to Help Detect Security Vulnerabilities GlobeN...
Read More
AGF Management Limited Reports Third Quarter 2020 Financial ResultsAGF Management Limited Reports Third Quarter 2020 Financial Results GlobeNewswire ...
Read More
Tampa General Hospital announces strategic partnership with Philips to innovate and improve patient experienceTampa General Hospital announces strategic partnership with Philips to innovate and improve patient ...
Read More
Athenex Announces FDA Allowance of IND Application for TCRT-ESO-A2, a TCR-T Cell TherapyAthenex Announces FDA Allowance of IND Application for TCRT-ESO-A2, a TCR-T Cell Therapy Ath...
Read More
VistaJet Announces New Market-Leading Sustainable Biofuel Partnership, Updates on Success of Its Current Sustainability Pledge and Calls for Further Action From Private Aviation IndustryVistaJet Announces New Market-Leading Sustainable Biofuel Partnership, Updates on Success of Its Cur...
Read More